Literature DB >> 27571996

Lethal Neonatal LTBL Associated with Biallelic EARS2 Variants: Case Report and Review of the Reported Neuroradiological Features.

Renata Oliveira1, Ewen W Sommerville2, Kyle Thompson2, Joana Nunes3, Angela Pyle2, Manuela Grazina4,5, Patrick F Chinnery6,7, Luísa Diogo8, Paula Garcia8, Robert W Taylor9.   

Abstract

Mitochondrial translation defects are important causes of early onset mitochondrial disease. Although the biochemical (combined respiratory chain deficiency) signature and neuroimaging are usually distinctive, they are not diagnostic as the genetic origin of mitochondrial translation defects is heterogeneous. We report a female child, born at term to non-consanguineous parents, who exhibited global hypotonia, failure to thrive, persistent and progressive hyperlactacidaemia with lactic acidosis, liver dysfunction and encephalopathy and died at the age of 5 months. Brain MRI revealed hypogenesis of the corpus callosum, T2 signal abnormalities in the medulla oblongata, pons, midbrain, thalami, cerebellar white matter, and a lactate peak on MRS. Muscle histochemistry showed cytochrome c oxidase (COX)-deficient and ragged-red fibres, while muscle biochemical studies showed decreased activities of mitochondrial respiratory chain complexes I and IV. Whole exome sequencing (WES) identified biallelic EARS2 (NM_001083614) variants, a previously reported start-loss (c.1>G, p.Met1?) variant and a novel missense (c.184A>T, p.Ile62Phe) variant. Patient fibroblasts and muscle homogenate displayed markedly decreased EARS2 protein levels, although decreased steady-state levels of complex I (NDUFB8) and complex IV (MT-CO1 and MT-CO2) subunits were only observed in muscle. Pathogenic variants in EARS2, encoding mitochondrial glutamyl-tRNA synthetase (mtGluR), are associated with Leukoencephalopathy involving the Thalamus and Brainstem with high Lactate (LTBL), a mitochondrial disorder characterised by a distinctive brain MRI pattern and a biphasic clinical course. We further outline the unique phenotypic spectrum of LTBL and review the neuroradiological features reported in all patients documented in the literature.

Entities:  

Keywords:  EARS2; Early onset mitochondrial disease; LTBL; Mitochondrial translation defects

Year:  2016        PMID: 27571996      PMCID: PMC5413444          DOI: 10.1007/8904_2016_581

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  19 in total

1.  Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing.

Authors:  Sarah E Calvo; Alison G Compton; Steven G Hershman; Sze Chern Lim; Daniel S Lieber; Elena J Tucker; Adrienne Laskowski; Caterina Garone; Shangtao Liu; David B Jaffe; John Christodoulou; Janice M Fletcher; Damien L Bruno; Jack Goldblatt; Salvatore Dimauro; David R Thorburn; Vamsi K Mootha
Journal:  Sci Transl Med       Date:  2012-01-25       Impact factor: 17.956

2.  A compound heterozygous EARS2 mutation associated with mild leukoencephalopathy with thalamus and brainstem involvement and high lactate (LTBL).

Authors:  Olcay Güngör; Ahmet Kağan Özkaya; Yavuz Şahin; Gülay Güngör; Cengiz Dilber; Kürşad Aydın
Journal:  Brain Dev       Date:  2016-04-23       Impact factor: 1.961

3.  Expanding the Clinical and Magnetic Resonance Spectrum of Leukoencephalopathy with Thalamus and Brainstem Involvement and High Lactate (LTBL) in a Patient Harboring a Novel EARS2 Mutation.

Authors:  Roberta Biancheri; Eleonora Lamantea; Mariasavina Severino; Daria Diodato; Marina Pedemonte; Denise Cassandrini; Alexandra Ploederl; Federica Trucco; Chiara Fiorillo; Carlo Minetti; Filippo M Santorelli; Massimo Zeviani; Claudio Bruno
Journal:  JIMD Rep       Date:  2015-04-09

4.  EARS2 mutations cause fatal neonatal lactic acidosis, recurrent hypoglycemia and agenesis of corpus callosum.

Authors:  Katharina Danhauser; Tobias B Haack; Bader Alhaddad; Marlen Melcher; Annette Seibt; Tim M Strom; Thomas Meitinger; Dirk Klee; Ertan Mayatepek; Holger Prokisch; Felix Distelmaier
Journal:  Metab Brain Dis       Date:  2016-01-16       Impact factor: 3.584

5.  Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation.

Authors:  Gert C Scheper; Thom van der Klok; Rob J van Andel; Carola G M van Berkel; Marie Sissler; Joél Smet; Tatjana I Muravina; Sergey V Serkov; Graziella Uziel; Marianna Bugiani; Raphael Schiffmann; Ingeborg Krägeloh-Mann; Jan A M Smeitink; Catherine Florentz; Rudy Van Coster; Jan C Pronk; Marjo S van der Knaap
Journal:  Nat Genet       Date:  2007-03-25       Impact factor: 38.330

6.  Absent Thalami Caused by a Homozygous EARS2 Mutation: Expanding Disease Spectrum of LTBL.

Authors:  Sietske H Kevelam; Femke C C Klouwer; Johanna M Fock; Gajja S Salomons; Marianna Bugiani; Marjo S van der Knaap
Journal:  Neuropediatrics       Date:  2015-11-30       Impact factor: 1.947

7.  Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia.

Authors:  Simon Edvardson; Avraham Shaag; Olga Kolesnikova; John Moshe Gomori; Ivan Tarassov; Tom Einbinder; Ann Saada; Orly Elpeleg
Journal:  Am J Hum Genet       Date:  2007-08-24       Impact factor: 11.025

8.  Multisystem fatal infantile disease caused by a novel homozygous EARS2 mutation.

Authors:  Beril Talim; Angela Pyle; Helen Griffin; Haluk Topaloglu; Aysegul Tokatli; Michael J Keogh; Mauro Santibanez-Koref; Patrick F Chinnery; Rita Horvath
Journal:  Brain       Date:  2012-09-24       Impact factor: 13.501

Review 9.  Mutations causing mitochondrial disease: What is new and what challenges remain?

Authors:  Robert N Lightowlers; Robert W Taylor; Doug M Turnbull
Journal:  Science       Date:  2015-09-24       Impact factor: 47.728

Review 10.  The Mitochondrial Aminoacyl tRNA Synthetases: Genes and Syndromes.

Authors:  Daria Diodato; Daniele Ghezzi; Valeria Tiranti
Journal:  Int J Cell Biol       Date:  2014-02-04
View more
  15 in total

Review 1.  Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.

Authors:  Rebecca Meyer-Schuman; Anthony Antonellis
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

2.  Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails.

Authors:  Molly E Kuo; Arjan F Theil; Anneke Kievit; May Christine Malicdan; Wendy J Introne; Thomas Christian; Frans W Verheijen; Desiree E C Smith; Marisa I Mendes; Lidia Hussaarts-Odijk; Eric van der Meijden; Marjon van Slegtenhorst; Martina Wilke; Wim Vermeulen; Anja Raams; Catherine Groden; Shino Shimada; Rebecca Meyer-Schuman; Ya Ming Hou; William A Gahl; Anthony Antonellis; Gajja S Salomons; Grazia M S Mancini
Journal:  Am J Hum Genet       Date:  2019-02-26       Impact factor: 11.025

Review 3.  When a common biological role does not imply common disease outcomes: Disparate pathology linked to human mitochondrial aminoacyl-tRNA synthetases.

Authors:  Ligia Elena González-Serrano; Joseph W Chihade; Marie Sissler
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

Review 4.  Ubiquitously Expressed Proteins and Restricted Phenotypes: Exploring Cell-Specific Sensitivities to Impaired tRNA Charging.

Authors:  Molly E Kuo; Anthony Antonellis
Journal:  Trends Genet       Date:  2019-12-12       Impact factor: 11.639

5.  Revisiting mitochondrial diagnostic criteria in the new era of genomics.

Authors:  Peter Witters; Ann Saada; Tomas Honzik; Marketa Tesarova; Stephanie Kleinle; Rita Horvath; Amy Goldstein; Eva Morava
Journal:  Genet Med       Date:  2017-10-26       Impact factor: 8.822

6.  Metabolic impact of pathogenic variants in the mitochondrial glutamyl-tRNA synthetase EARS2.

Authors:  Min Ni; Lauren F Black; Chunxiao Pan; Hieu Vu; Jimin Pei; Bookyung Ko; Ling Cai; Ashley Solmonson; Chendong Yang; Kimberly M Nugent; Nick V Grishin; Chao Xing; Elizabeth Roeder; Ralph J DeBerardinis
Journal:  J Inherit Metab Dis       Date:  2021-04-27       Impact factor: 4.750

7.  Functionally pathogenic EARS2 variants in vitro may not manifest a phenotype in vivo.

Authors:  Nathan McNeill; Alessia Nasca; Aurelio Reyes; Benjamin Lemoine; Brandi Cantarel; Adeline Vanderver; Raphael Schiffmann; Daniele Ghezzi
Journal:  Neurol Genet       Date:  2017-07-14

8.  Expanding the clinical phenotype of IARS2-related mitochondrial disease.

Authors:  Barbara Vona; Reza Maroofian; Emanuele Bellacchio; Maryam Najafi; Kyle Thompson; Ahmad Alahmad; Langping He; Najmeh Ahangari; Abolfazl Rad; Sima Shahrokhzadeh; Paulina Bahena; Falk Mittag; Frank Traub; Jebrail Movaffagh; Nafise Amiri; Mohammad Doosti; Reza Boostani; Ebrahim Shirzadeh; Thomas Haaf; Daria Diodato; Miriam Schmidts; Robert W Taylor; Ehsan Ghayoor Karimiani
Journal:  BMC Med Genet       Date:  2018-11-12       Impact factor: 2.103

9.  Pathogenic variants in glutamyl-tRNAGln amidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder.

Authors:  Marisa W Friederich; Sharita Timal; Christopher A Powell; Cristina Dallabona; Alina Kurolap; Sara Palacios-Zambrano; Drago Bratkovic; Terry G J Derks; David Bick; Katelijne Bouman; Kathryn C Chatfield; Nadine Damouny-Naoum; Megan K Dishop; Tzipora C Falik-Zaccai; Fuad Fares; Ayalla Fedida; Ileana Ferrero; Renata C Gallagher; Rafael Garesse; Micol Gilberti; Cristina González; Katherine Gowan; Clair Habib; Rebecca K Halligan; Limor Kalfon; Kaz Knight; Dirk Lefeber; Laura Mamblona; Hanna Mandel; Adi Mory; John Ottoson; Tamar Paperna; Ger J M Pruijn; Pedro F Rebelo-Guiomar; Ann Saada; Bruno Sainz; Hayley Salvemini; Mirthe H Schoots; Jan A Smeitink; Maciej J Szukszto; Hendrik J Ter Horst; Frans van den Brandt; Francjan J van Spronsen; Joris A Veltman; Eric Wartchow; Liesbeth T Wintjes; Yaniv Zohar; Miguel A Fernández-Moreno; Hagit N Baris; Claudia Donnini; Michal Minczuk; Richard J Rodenburg; Johan L K Van Hove
Journal:  Nat Commun       Date:  2018-10-03       Impact factor: 14.919

10.  Instability of the mitochondrial alanyl-tRNA synthetase underlies fatal infantile-onset cardiomyopathy.

Authors:  Ewen W Sommerville; Xiao-Long Zhou; Monika Oláhová; Janda Jenkins; Liliya Euro; Svetlana Konovalova; Taru Hilander; Angela Pyle; Langping He; Sultan Habeebu; Carol Saunders; Anna Kelsey; Andrew A M Morris; Robert McFarland; Anu Suomalainen; Gráinne S Gorman; En-Duo Wang; Isabelle Thiffault; Henna Tyynismaa; Robert W Taylor
Journal:  Hum Mol Genet       Date:  2019-01-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.